自体主导多囊性病:2025年核心课程
Craig E Gordon1, Pranav S Garimella2, Ronald D Perrone1
1Division of Nephrology, Department of Medicine, School of Medicine, Tufts University, Boston, Massachusetts.
概括
自体主导多囊性病 (ADPKD) 是衰竭的常见遗传原因. 诊断,预后和治疗方面的进展,包括新的治疗方法,为ADPKD患者提供了更好的结果.
科学领域:
- 肝脏病学
- 遗传学
- 内部医学
背景情况:
- 自体主导多囊性病 (ADPKD) 是导致衰竭的主要遗传原因.
- 最近的科学进展提高了ADPKD和外并发症的诊断,预后和治疗策略.
- 现在可以通过整合体积,功能和遗传突变数据来对ADPKD进展的风险分层.
研究的目的:
- 提供ADPKD诊断和治疗的全面概述.
- 讨论ADPKD的和外表现,包括疼痛,囊感染,多囊性肝病和内动脉瘤.
- 涵盖ADPKD患者的高血压管理,妇女健康和怀孕.
主要方法:
- 审查当前的科学文献和临床实践指南.
- 整合有关诊断标记,预后指标和治疗干预措施的数据.
- 符合最新的病:改善ADPKD的全球结果 (KDIGO) 指南.
主要成果:
- 全体积,功能和基因突变状态预测ADPKD进展为功能衰竭.
- 托尔瓦普坦是一种V2受体抗剂,目前是FDA批准的唯一一种减缓ADPKD进展的疗法.
- 其他多种疗法正在积极研究ADPKD治疗.
结论:
- 准确的风险评估可以及时启动疾病修饰疗法.
- 综合管理策略应用于脏和外表现的ADPKD.
- 目前的指导方针和新兴疗法为ADPKD患者提供了更好的前景.
关键词:
自体主导多囊性病相关概念视频
Chronic Kidney Disease I: Introduction
67
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
67
Renal Corpuscle
3.3K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
3.3K
Chronic Kidney Disease III: Interprofessional Care
78
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
78
Chronic Kidney Disease II: Clinical Manifestations
87
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
87
Kidney Structure
70.5K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
70.5K
Renal Drug Clearance: Overview
330
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
330


